Viewing StudyNCT00516412



Ignite Creation Date: 2024-05-05 @ 6:37 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00516412
Status: COMPLETED
Last Update Posted: 2015-09-29
First Post: 2007-08-14

Brief Title: Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Sponsor: Swiss Group for Clinical Cancer Research
Organization: Swiss Group for Clinical Cancer Research

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Keywords:
Name View
contiguous stage II mantle cell lymphoma View
noncontiguous stage II mantle cell lymphoma View
recurrent mantle cell lymphoma View
stage I mantle cell lymphoma View
stage III mantle cell lymphoma View
stage IV mantle cell lymphoma View